Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver
disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric …

Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …

Microplastics (MPs), which are emerging environmental pollutants, remain uncertainties in
their toxic mechanism. MPs have been linked to severe liver metabolic disorders and …

Cerebral amyloid-β (Aβ) accumulation due to impaired Aβ clearance is a pivotal event in the
pathogenesis of Alzheimer's disease (AD). Considerable brain-derived Aβ is cleared via …

Nonalcoholic fatty liver disease (NAFLD) is a global and growing health concern. Emerging
evidence points toward metabolic inflammation as a key process in the fatty liver that …

Non-alcoholic fatty liver disease (NAFLD) has emerged as the hepatic component of the
metabolic syndrome and now seemingly affects one-fourth of the world population. Features …

Non-alcoholic fatty liver disease (NAFLD) is a metabolic disease characterized by multiple
pathologies. The progression of dementia with NAFLD may be affected by various risk …

Non-alcoholic fatty liver disease (NAFLD) and its complication non-alcoholic steatohepatitis
(NASH) are important causes of liver disease worldwide. Recently, a significant association …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) has been associated with
mild cerebral dysfunction and cognitive decline, although the exact pathophysiological …

Pathogenesis of neurodegenerative diseases involves dysfunction of mitochondria, one of
the most important cell organelles in the brain, with its most prominent roles in producing …